These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


424 related items for PubMed ID: 32493084

  • 41. Intratympanic steroid therapy in moderate sudden hearing loss: a randomized, triple-blind, placebo-controlled trial.
    Filipo R, Attanasio G, Russo FY, Viccaro M, Mancini P, Covelli E.
    Laryngoscope; 2013 Mar; 123(3):774-8. PubMed ID: 23378346
    [Abstract] [Full Text] [Related]

  • 42. Hyperbaric Oxygen Therapy as Salvage Therapy for Sudden Sensorineural Hearing Loss.
    Ajduk J, Ries M, Trotic R, Marinac I, Vlatka K, Bedekovic V.
    J Int Adv Otol; 2017 Apr; 13(1):61-64. PubMed ID: 28555597
    [Abstract] [Full Text] [Related]

  • 43. Potential Benefits of Combination Therapy as Primary Treatment for Sudden Sensorineural Hearing Loss.
    Lee JB, Choi SJ.
    Otolaryngol Head Neck Surg; 2016 Feb; 154(2):328-34. PubMed ID: 26556463
    [Abstract] [Full Text] [Related]

  • 44. Combined Acupuncture-Hyperbaric Oxygen-Steroids Therapy for Idiopathic Sudden Sensorineural Hearing Loss: A Retrospective Observational Study.
    Lee CJ, Chen HC, Shih CP, Lin YY, Kuo CY, Liu SC.
    J Altern Complement Med; 2021 Jul; 27(7):588-595. PubMed ID: 33945302
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Simultaneous versus subsequent intratympanic dexamethasone for idiopathic sudden sensorineural hearing loss.
    Park MK, Lee CK, Park KH, Lee JD, Lee CG, Lee BD.
    Otolaryngol Head Neck Surg; 2011 Dec; 145(6):1016-21. PubMed ID: 21817157
    [Abstract] [Full Text] [Related]

  • 50. Efficacy of Intratympanic Glucocorticoid Steroid Administration Therapy as an Initial Treatment for Idiopathic Sudden Sensorineural Hearing Loss During the COVID-19 Pandemic.
    Tsuda T, Hanada Y, Wada K, Fujiwara E, Takeda K, Nishimura H.
    Ear Nose Throat J; 2023 Dec; 102(12):772-779. PubMed ID: 34247535
    [Abstract] [Full Text] [Related]

  • 51. Steroid-based treatments for patients with total sudden sensorineural hearing loss.
    Nakache G, Migirov L, Trommer S, Drendel M, Wolf M, Henkin Y.
    Acta Otolaryngol; 2015 Sep; 135(9):907-13. PubMed ID: 25857447
    [Abstract] [Full Text] [Related]

  • 52. Intratympanic steroids as a salvage therapy for severe to profound idiopathic sudden sensorineural hearing loss.
    Covelli E, Altabaa K, Verillaud B, Camous D, Hautefort C, Barbara M, Herman P, Kania R.
    Acta Otolaryngol; 2018 Nov; 138(11):966-971. PubMed ID: 30380957
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Comparison of Therapeutic Results with/without Additional Hyperbaric Oxygen Therapy in Idiopathic Sudden Sensorineural Hearing Loss: A Randomized Prospective Study.
    Tong B, Niu K, Ku W, Xie W, Dai Q, Hellström S, Duan M.
    Audiol Neurootol; 2021 Nov; 26(1):11-16. PubMed ID: 32535600
    [Abstract] [Full Text] [Related]

  • 55. Efficacy of Concomitant Intratympanic Steroid Injection for Sudden Deafness According to Initial Hearing Loss.
    Yang HC, Cho YB, Jang CH, Cho HH.
    Otol Neurotol; 2015 Dec; 36(10):1604-9. PubMed ID: 26485600
    [Abstract] [Full Text] [Related]

  • 56. Management of Idiopathic Sudden Sensorineural Hearing Loss (ISSNHL) Intratympanic Platelet-Rich Plasma (PRP) Versus Intratympanic Steroid Injections: A Cross-Sectional Study.
    Shawky M.
    Otolaryngol Pol; 2024 Jun 30; 78(3):1-6. PubMed ID: 38808642
    [Abstract] [Full Text] [Related]

  • 57. Intratympanic dexamethasone and hyaluronic acid in patients with low-frequency and Ménière's-associated sudden sensorineural hearing loss.
    Selivanova OA, Gouveris H, Victor A, Amedee RG, Mann W.
    Otol Neurotol; 2005 Sep 30; 26(5):890-5. PubMed ID: 16151334
    [Abstract] [Full Text] [Related]

  • 58. The efficiency of intratympanic dexamethasone injection as a sequential treatment after initial systemic steroid therapy for sudden sensorineural hearing loss.
    Lee JB, Choi SJ, Park K, Park HY, Choo OS, Choung YH.
    Eur Arch Otorhinolaryngol; 2011 Jun 30; 268(6):833-9. PubMed ID: 21221620
    [Abstract] [Full Text] [Related]

  • 59. Intratympanic steroids for combined treatment of idiopathic sudden hearing loss: when is it too late?
    Amarillo E, Navarro A, Hernández-García E, Plaza G.
    Acta Otolaryngol; 2019 Jul 30; 139(7):632-635. PubMed ID: 31124732
    [Abstract] [Full Text] [Related]

  • 60. Clinical characteristics and correlation between hearing outcomes after different episodes of recurrent idiopathic sudden sensorineural hearing loss.
    Wu PH, Lee CY, Chen HC, Lee JC, Chu YH, Cheng LH, Wang CH, Shih CP.
    Auris Nasus Larynx; 2021 Oct 30; 48(5):870-877. PubMed ID: 33549393
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 22.